MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Spectrum of hyperkinetic movement disorders in a Tunisian Cohort: an observational study

    S. Laroussi, S. Daoud, N. Bouattour, S. Sakka, K. Moalla, M. Damak, N. Farhat, C. Mhiri (Sfax, Tunisia)

    Objective: Recall clinical situations of hyperkinetic movement disorders (HMD) in a Tunisian cohort. Background: HMD result from a dysfunction of the basal ganglia(BG) and are…
  • 2023 International Congress

    Investigate the association of MAPT haplotype and neuroanatomical structure and its influence on the risk of Parkinson’s disease

    E. Yu, C. Tremblay, A. Vo, Y. Sosero, Z. Gan-Or, A. Dagher, L. Liu ()

    Objective: To investigate if the vulnerability of Parkinson’s Disease (PD) can be reflected in the neuroanatomical structure in different MAPT haplotype carriers. Background: It has…
  • 2023 International Congress

    Linking volume of tissue activated to neural oscillations in deep brain stimulation

    A. Kutuzova, C. Graef, B. Lonergan, Y. Tai, S. Haar (London, United Kingdom)

    Objective: Exploring the effect of deep brain stimulation (DBS) settings on neural oscillations in Parkinson’s disease (PD) patients with subthalamic nucleus (STN) DBS and their…
  • 2023 International Congress

    Levodopa-carbidopa intestinal gel for managing severe refractory tremors of idiopathic Parkinson’s disease: Case Series

    M. Abu Al-Melh, N. Abdelall, T. Al-Otaibi (Ahmadi governorate, Kuwait)

    Objective: To report our experience with the use of levodopa-carbidopa intestinal gel (LCIG) infusion therapy for the treatment of four patients with idiopathic Parkinson’s disease…
  • 2023 International Congress

    Early versus late levodopa administration in Parkinson’s disease: Comparative study

    A. Akid, I. Kacem, A. Guedi, Y. Abida, S. Mrabet, A. Souissi, A. Gharbi, A. Nasri, R. Gouider (Tunis, Tunisia)

    Objective: To evaluate levodopa-sparing strategy in terms of motor decline and complications. Background: Levodopa remains the gold standard for treatment of Parkinson’s disease(PD), as it…
  • 2023 International Congress

    Botulinum toxin treatment for focal dystonia in a Tunisian cohort

    M. Jamoussi, H. Benrhouma, M. Ben Hafsa, T. Ben Younes, Z. Miladi, H. Klaa, I. Kraoua, N. Gouider Khouja, I. Ben Youssef (Tunis, Tunisia)

    Objective: Our aim was to report the etiology, management and outcome of patients with focal dystonia. Background: Focal dystonia (FD) is characterized by involuntary muscle…
  • 2023 International Congress

    Restless legs syndrome may be associated with freezing of gait, start hesitation and falls in Parkinson’s disease

    M. Isayan, H. Hovakimyan, S. Khachatryan, Z. Tavadyan (Yerevan, Armenia)

    Objective: We aimed to assess the association between RLS and freezing of gait, start hesitation and falls. Background: Parkinson’s disease (PD) is a neurodegenerative disease…
  • 2023 International Congress

    Safety and efficacy of focused ultrasound thalamotomy in essential tremor: a real scenario within the public health system.

    D. Vilas, M. Tardáguila, L. Ispierto, J. Muñoz, M. Gea, A. González, R. álvarez (badalona, Spain)

    Objective: To describe the safety and efficacy of focused ultrasound thalamotomy (FUS) in a cohort of patients with essential tremor (ET) within the Spanish public…
  • 2023 International Congress

    Pain and sleep in Parkinson’s disease

    A. Zarnoveanu, S. Diaconu, B. Ciopleias, L. Ungureanu, T. Dragan, B. Ciocanescu, T. Moldovan, C. Falup-Pecurariu (Brasov, Romania)

    Objective: Pain and sleep disturbances are among the most frequently encountered non-motor symptoms in Parkinson’s disease (PD). Background: The aim of this study was to…
  • 2023 International Congress

    Deep Brain Stimulation in Parkinson’s Disease: real-world outcomes at a single centre

    B. Lonergan, M. Ciocca, A. Bocum, D. Nandi, P. Bain, G. Charlesworth, N. Pavese, Y. Tai (London, United Kingdom)

    Objective: To describe the clinical outcomes in PD patients following DBS and analyse whether certain demographic and clinical factors are associated with poor outcomes. Background:…
  • « Previous Page
  • 1
  • …
  • 449
  • 450
  • 451
  • 452
  • 453
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley